Harrow (HROW) Depreciation & Amortization (CF) (2010 - 2026)

Harrow's (HROW) quarterly Depreciation & Amortization (CF) came in at $455000.0 in Q1 2026, down 2.15% year-on-year from $465000.0 in Q1 2025, and down 1.94% quarter-over-quarter from $464000.0 in Q4 2025.

Harrow (HROW) Depreciation & Amortization (CF) (2010 - 2026) Analysis & Trends

Harrow's Depreciation & Amortization (CF) history runs 17 years deep, the most recent figure standing at $455000.0 for Q1 2026.

  • On a quarterly basis, Depreciation & Amortization (CF) fell 2.15% year-over-year to $455000.0 in Q1 2026; TTM through Mar 2026 was $1.9 million, a 1.17% increase from a year earlier, with the FY2025 full-year figure at $1.9 million, up 3.51% from the prior year.
  • Depreciation & Amortization (CF) retreated to $455000.0 in Q1 2026 per HROW's latest filing, from $464000.0 in the prior quarter.
  • Across five years, Depreciation & Amortization (CF) topped out at $497000.0 in Q3 2024 and bottomed at $247000.0 in Q3 2022.
  • The 5-year median for Depreciation & Amortization (CF) is $435000.0 (2023), against an average of $425117.6.
  • Across the five-year window, Depreciation & Amortization (CF) slumped 38.1% in 2022 and surged 63.97% in 2023, its largest moves.
  • Year by year, Depreciation & Amortization (CF) stood at $387000.0 in 2022, then climbed by 12.4% to $435000.0 in 2023, then gained by 7.59% to $468000.0 in 2024, then fell by 0.85% to $464000.0 in 2025, then slipped by 1.94% to $455000.0 in 2026.
  • Per Business Quant, the three latest HROW Depreciation & Amortization (CF) figures stand at $455000.0 (Q1 2026), $464000.0 (Q4 2025), and $490000.0 (Q3 2025).

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Depreciation & Amortization (Qtr)
1 Haleon 87.22 Bn 85.35 Bn - -
2 Teva Pharmaceutical Industries 39.60 Bn 35.87 Bn 1.97 Bn 239.00 Mn
3 Zoetis 31.46 Bn 29.52 Bn 1.62 Bn 119.00 Mn
4 Takeda Pharmaceutical 26.49 Bn 22.44 Bn 4.39 Bn 1.04 Bn
5 United Therapeutics 23.03 Bn 20.88 Bn 648.10 Mn 22.60 Mn
6 Universe Pharmaceuticals 23.03 Bn -10.56 Bn - -
7 Viatris 20.90 Bn 19.09 Bn 1.16 Bn 676.10 Mn
8 Neurocrine Biosciences 17.50 Bn 16.19 Bn 800.70 Mn 7.20 Mn
9 Elanco Animal Health 12.33 Bn 11.91 Bn 785.00 Mn 172.00 Mn
10 Harrow 1.56 Bn 1.47 Bn 27.05 Mn 455,000.00

Historic Data

Download Data
DateValue
Mar 31, 2026 455,000.00
Mar 31, 2026 455,000.00
Dec 31, 2025 464,000.00
Dec 31, 2025 464,000.00
Sep 30, 2025 490,000.00
Sep 30, 2025 490,000.00
Jun 30, 2025 496,000.00
Jun 30, 2025 496,000.00
Mar 31, 2025 465,000.00
Mar 31, 2025 465,000.00
Dec 31, 2024 468,000.00
Dec 31, 2024 468,000.00
Sep 30, 2024 497,000.00
Sep 30, 2024 497,000.00
Jun 30, 2024 453,000.00
Jun 30, 2024 453,000.00
Mar 31, 2024 432,000.00
Mar 31, 2024 432,000.00
Dec 31, 2023 435,000.00
Dec 31, 2023 435,000.00